Bloomberg Expert Sees Bullish Trend on MD's 15-Minute Chart Expansion.
ByAinvest
Thursday, Jul 10, 2025 10:21 am ET1min read
MDWD--
According to recent market analysis, MediWound's stock is expected to drop by -7.71% and reach $17.89 per share by August 7, 2025 [1]. This prediction is based on the current Fear & Greed Index of 39 (Fear) and a Bullish sentiment, with 11/30 (37%) green days over the last 30 days. The 50-Day Simple Moving Average (SMA) stands at $19.70, while the 200-Day SMA is $18.00. The 14-Day Relative Strength Index (RSI) is at 49.82, indicating a moderately bullish trend.
Investors should be cautious, as the stock is trading 15.68% below the forecasted price. The current price of $20.69 suggests a potential overvaluation. Short-term forecasts indicate that the price could dip as low as $0.00 by an invalid date, representing a -100.00% dip from today's rates [1].
For 2025, MediWound is anticipated to trade within a range of $17.85 to $19.38, with an average annualized price of $18.33. This could result in a potential return on investment of -6.33% compared to the current rates. Given the expected dip, investors could profit from negative activity by shorting MDWD [1].
For 2026, the stock is forecasted to trade between $18.13 and $22.38, with an average price of $18.47. The most bullish month is December, with a potential increase of 8.15% [1].
In 2027, the price prediction is bullish, with an expected high point of $22.33 in January and a low of $20.14 in September. The average price for the year is projected to be $21.14 [1].
For 2028, the outlook suggests a possible uptrend, with an expected price of $23.14, representing an 11.82% increase from the current price [1].
In 2029, MediWound's value is forecasted to increase, potentially reaching an average price of $22.59. The price is predicted to fluctuate between a low of $20.11 in November and a high of $24.99 in June [1].
For 2030, forecasts suggest a significant growth, with expected fluctuation ranging from $20.82 to $31.69. Investors might anticipate a potential ROI of 53.17% [1].
Overall, the long-term forecast for MediWound is bullish, with potential highs of $31.69 and lows of $17.85 over the period [1].
References
[1] https://coincodex.com/stock/MDWD/price-prediction/
NAKA--
Based on the MD's 15-minute chart, the Bollinger Bands have expanded upward, and a bullish Marubozu was observed on July 10, 2025 at 10:15. This suggests that the market is being driven by strong buying activity, with buyers exerting control over the market. As a result, there is a high likelihood of continued bullish momentum.
MediWound (MDWD) has shown notable bullish momentum on its 15-minute chart, with Bollinger Bands expanding upward and a bullish Marubozu candle forming on July 10, 2025, at 10:15. This technical pattern indicates a strong buying force driving the market, suggesting that bullish momentum is likely to persist.According to recent market analysis, MediWound's stock is expected to drop by -7.71% and reach $17.89 per share by August 7, 2025 [1]. This prediction is based on the current Fear & Greed Index of 39 (Fear) and a Bullish sentiment, with 11/30 (37%) green days over the last 30 days. The 50-Day Simple Moving Average (SMA) stands at $19.70, while the 200-Day SMA is $18.00. The 14-Day Relative Strength Index (RSI) is at 49.82, indicating a moderately bullish trend.
Investors should be cautious, as the stock is trading 15.68% below the forecasted price. The current price of $20.69 suggests a potential overvaluation. Short-term forecasts indicate that the price could dip as low as $0.00 by an invalid date, representing a -100.00% dip from today's rates [1].
For 2025, MediWound is anticipated to trade within a range of $17.85 to $19.38, with an average annualized price of $18.33. This could result in a potential return on investment of -6.33% compared to the current rates. Given the expected dip, investors could profit from negative activity by shorting MDWD [1].
For 2026, the stock is forecasted to trade between $18.13 and $22.38, with an average price of $18.47. The most bullish month is December, with a potential increase of 8.15% [1].
In 2027, the price prediction is bullish, with an expected high point of $22.33 in January and a low of $20.14 in September. The average price for the year is projected to be $21.14 [1].
For 2028, the outlook suggests a possible uptrend, with an expected price of $23.14, representing an 11.82% increase from the current price [1].
In 2029, MediWound's value is forecasted to increase, potentially reaching an average price of $22.59. The price is predicted to fluctuate between a low of $20.11 in November and a high of $24.99 in June [1].
For 2030, forecasts suggest a significant growth, with expected fluctuation ranging from $20.82 to $31.69. Investors might anticipate a potential ROI of 53.17% [1].
Overall, the long-term forecast for MediWound is bullish, with potential highs of $31.69 and lows of $17.85 over the period [1].
References
[1] https://coincodex.com/stock/MDWD/price-prediction/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet